Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

MPR
empr.com > news > about-30-of-pediatric-surgery-patients-receive-opioid-rx

About 30% of Pediatric Surgery Patients Receive Opioid Rx

1+ week, 6+ day ago   (277+ words) About 31% of pediatric surgery patients receive an opioid prescription at discharge, according to a study published online June 23 in the Journal of the America... HealthDay News — About 31% of pediatric surgery patients receive an opioid prescription at discharge, according to a…...

MPR
empr.com > home > news > june-2026-recap-of-drug-updates

June 2026 Recap of Drug Updates

3+ week, 4+ day ago   (69+ words) Medical Professionals Reference The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of June 2026. The chart below provides highlights of key monograph updates made this month (not an…...

MPR
empr.com > news > fda-approves-lumvoa-veligrotug-vvze-thyroid-eye-disease

FDA Approves Lumvoa for Active and Chronic Thyroid Eye Disease

3+ week, 5+ day ago   (278+ words) The Food and Drug Administration (FDA) has approved Lumvoa™ (veligrotug-vvze) for the treatment of thyroid eye disease (TED) regardless of TED activity or duration. Veligrotug is a humanized IgG1 monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor (IGF…...

MPR
empr.com > news > fda-approves-ibrance-metastatic-breast-cancer-maintenance

Ibrance Combo Regimen Approved for HR+, HER2+ Advanced Breast Cancer

1+ mon, 1+ day ago   (466+ words) Ibrance is now FDA approved in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for HR-positive, HER2-positive metastatic breast cancer maintenance treatment, following induction therapy. The Food and Drug Administration (FDA) has approved Ibrance® (palbociclib) in combination with…...

MPR
empr.com > news > modified-mrna-influenza-vaccine-superior-to-inactivated-influenza-vaccine

Modified mRNA Influenza Vaccine Superior to Inactivated Influenza Vaccine

8+ mon, 21+ hour ago   (297+ words) Researchers found that the relative efficacy of the modRNA vaccine was 34.5% against influenza-like illness compared with the control vaccine, on the basis of 57 and 87 cases in the modRNA and control... HealthDay News — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine…...

MPR
empr.com > news > aglatimagene-besadenovec-valacyclovir-ups-dfs-in-localized-prostate-cancer

Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer

1+ mon, 1+ week ago   (307+ words) Medical Professionals Reference HealthDay News — For patients with localized prostate cancer, aglatimagene besadenovec, an adenoviral-based immunotherapy, plus valacyclovir is associated with longer disease-free survival (DFS) than placebo plus valacyclovir when added to standard radiotherapy, according to a study published in…...

MPR
empr.com > news > upcoming-billing-change-could-make-pregnancy-pricier

Upcoming Billing Change Could Make Pregnancy Pricier

1+ mon, 2+ week ago   (1449+ words) HealthDay News — Having a baby in the United States is about to get more complicated. Under new billing codes that take effect in January, doctors who manage maternity care will start charging à la carte for visits and services related…...

MPR
empr.com > news > rfk-jr-seeks-to-peek-at-americans-medical-records-for-clues-on-autism-and-vaccines

RFK Jr. Seeks To Peek At Americans' Medical Records For Clues On Autism And Vaccines

1+ mon, 2+ week ago   (1650+ words) HealthDay News — US health secretary Robert F. Kennedy Jr. is pursuing federal government access to most Americans’ medical records, in a quest to research a link between vaccines and autism, a connection the medical establishment studied for decades and flatly…...

MPR
empr.com > news > fda-approves-zaynich-complicated-urinary-tract-infections

Zaynich Approved for Complicated Urinary Tract Infections in Adults

1+ mon, 2+ week ago   (291+ words) Study participants were randomly assigned 2:1 to receive either FEP-ZID (cefepime 2g and zidebactam 1g) or meropenem 1g intravenously every 8 hours for 7 to 10 days. Dosage adjustments were made for patients with renal impairment. The study analyzed the microbiological modified intent-to-treat population (mMITT), which consisted…...

MPR
empr.com > news > fda-extends-camizestrant-review-serena-6

FDA Extends Review for Camizestrant in Advanced Breast Cancer

1+ mon, 4+ week ago   (364+ words) Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest…...